GenoPalate Closes $4M Series A Financing Round


GenoPalate, Inc., a Milwaukee-based early-stage nutritional genomics company, closed a $4m Series A financing round.

Backers included local investors.

The company intends to use the funds to expand digital marketing and to continue the development of its research databases for addressing personalized nutrition, health and wellness, and chronic metabolic diseases such as type-2 diabetes, obesity, and metabolic syndrome.

Founded in 2016 by Yi Sherry Zhang, a Ph.D. geneticist and former professor at the Medical College of Wisconsin, GenoPalate provides nutrigenomics testing and analytical services for health-conscious consumers seeking to make healthy dietary choices. Using proprietary algorithms, the company interprets the customer’s DNA to help determine a personalized nutrition profile that shows them which foods are good and bad for their health. Its home nutrition DNA test analyzes 100+ genetic markers that determine a person’s specific needs for vital nutrients such as carbohydrates, vitamin D, and sodium. That combined with millions of nutritional variables produces a personalized report recommending foods that will provide the most benefit for a person’s health.



Join the discussion